Galectin Therapeutics
GALT
GALT
62 hedge funds and large institutions have $13M invested in Galectin Therapeutics in 2014 Q4 according to their latest regulatory filings, with 9 funds opening new positions, 22 increasing their positions, 16 reducing their positions, and 8 closing their positions.
Holders
62
Holders Change
-1
Holders Change %
-1.59%
% of All Funds
1.65%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
9
Increased
22
Reduced
16
Closed
8
Calls
$15K
Puts
$679K
Net Calls
-$664K
Net Calls Change
+$164K
Top Buyers
1 |
1
D.E. Shaw & Co
New York
|
$261K |
2 |
2
Morgan Stanley
New York
|
$347K |
3 |
BFA
3
BlackRock Fund Advisors
San Francisco,
California
|
$1.75M |
4 |
AFM
4
Anson Funds Management
Dallas,
Texas
|
$195K |
5 |
VKH
5
Virtu KCG Holdings
New York
|
$138K |